All of us who have stayed with this company must continue to be patient. If Acne trials show good results, we should see $6. If BUV trials show good results, we may see the partner show real interest in taking over XOMA on the cheap, like maybe $7.50 or so. The trials for the other indications will take another $60+ million and 1+ year to complete. Partner easily has the cash, especially if € gains another few % in the next few months.